Cross-species Comparison of Smad3 Expression in Hepatocellular Carcinoma Tissues

ZHU Ling-qun,CAO Ji,LU Xiao-xu,LI Yuan,OU Chao,SU Jian-jia,YANG Chun
DOI: https://doi.org/10.3969/j.issn.1000-4718.2013.01.011
2013-01-01
Abstract:AIM: To study the expression of Smad3 and its significance in hepatocellular carcinoma(HCC) in different species including human,rat and tree shrew,and to verify the feasibility of cross-species oncogenomic approach.METHODS: Real-time fluorescent quantitative polymerase chain reaction and Western blotting were applied to detect the expression of Smad3 at mRNA and protein levels in HCC tissues,corresponding HCC adjacent liver tissues and normal liver tissues collected from different species including human,rat and tree shrew.RESULTS: The mRNA expression of Smad3 in HCC tissues of human,rat and tree shrew was lower than those in the corresponding HCC tissues adjacent liver tissues.The mRNA level of Smad3 in HCC tissues of rat was lower than those in its normal liver tissues,while that in HCC adjacent tissues of tree shrew appeared higher than those in the normal liver tissues.No significant difference of Smad3 expression in other tissues was observed.The protein levels of Smad3 in HCC of human and rat were lower than those in the corresponding HCC adjacent liver tissues and the normal liver tissues.However,the protein expression of Smad3 was at a low level in HCC tissues of tree shrew and was lower than that in the HCC adjacent liver tissues and the normal liver tissues,although without statistical difference.The differences of Smad3 expression between HCC adjacent liver tissues and normal liver tissues in all the 3 species were not statistically significant.CONCLUSION: Smad3 is lowly expressed in HCC tissues of different species,suggesting that it might play a pivotal role in hepatocarcinogenesis and be applied as a key molecular target in HCC prevention and treatment.
What problem does this paper attempt to address?